LAB Research's Canadian laboratory receives OECD-GLP compliance status

Jun 2 2010

All three sites of LAB Research have now received OECD-GLP compliance status

LAB Research Inc. ("LAB" or "LAB Research"), (TSX: LRI), a Canadian-based global non-clinical contract research organization ("CRO"), today announced that its Canadian laboratory has received a Good Laboratory Practices ("GLP") recognition from the Standards Council of Canada ("SCC").

GLP compliance of the site has been recognized by formal document issued in May 2010 under the Standards Council of Canada GLP Compliance Program based upon an inspection and study audits conducted in November 2009 in the area(s) of Analytical and Clinical Chemistry, ADME, Bioanalytical, Immunology, Safety Pharmacology, Toxicokinetics and Toxicity testing of Pharmaceuticals.

"The confirmation of our GLP compliance status reaffirms the Canadian site's GLP compliance to OECD-GLP standards following the successful audit by the German authorities several years ago," commented Luc Mainville, President and Chief Executive Officer of LAB Research.

"This successful OECD-GLP Inspection of our Canadian laboratory also follows successful GLP audits of each of our Danish and Hungarian laboratories. We are pleased to offer the greatest level of quality and GLP compliant environment to our clients around the world. These positive GLP audits will help us broaden our clientele following our service and site expansions that positioned LRI as a high quality, global full service non-clinical CRO," added Luc Mainville.